Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?
Schmidt, S.; Hohlfeld, R.
Der Nervenarzt 66(4): 304-307
1995
ISSN/ISBN: 0028-2804 PMID: 7783819 Document Number: 449783
Document emailed within 1 workday
Related Documents
Vass, K.; Schmied, M. 1996: Current therapy of multiple sclerosis Wiener Medizinische Wochenschrift 146(19-20): 514-519Reichel, D.; Kölmel, H.W. 1995: Multiple sclerosis--current status of therapy Zeitschrift für Arztliche Fortbildung 89(2): 151-158
Popescu, V.; Bleahu, D. 1992: The indications for intravenous immunoglobulins in pediatric practice Pediatrie 41(1): 37-45
Caputo, D.; Zaffaroni, M.; Procaccia, S. 1982: CSF immunoglobulins G in multiple sclerosis Bollettino dell'Istituto Sieroterapico Milanese 61(5): 393-403
Yabuki, S.; Hayabara, T.; Ikeda, H.; Otsuki, S. 1975: Cerebrospinal fluid immunoglobulins in multiple sclerosis Rinsho Shinkeigaku 15(8): 528-534
Costello, R.; Papadopoulas, N.M. 1989: Bence Jones immunoglobulins in the urine of patients with multiple sclerosis Clinical Chemistry 35(1): 186-187
Lubetzki, C.; Lombrail, P.; Hauw, J.J.; Baumann, N.; Zalc, B. 1987: Binding of immunoglobulins of the cerebrospinal fluid of multiple sclerosis patients to oligodendrocytes in culture Pathologie-Biologie 35(3): 314-318
Shorr, J.; Ziser, A.; Hochstadt, F.; Ovadia, H.; Abramsky, O. 1982: Diagnostic value of cerebrospinal fluid oligoclonal immunoglobulins in multiple sclerosis and inflammatory disease of the nervous system Harefuah 103(10): 243-245
Gadoth, N.; Melamed, E.; Miller, A.; Steiner, I.; Abramsky, O. 1999: Intravenous immunoglobulin treatment in multiple sclerosis Neurology 52(1): 214-215
Rumbach, L. 2001: Therapeutic indications targeting etiology of progressive multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 2): 1001-1007
Leary, S.M.; Thompson, A.J. 2000: Current management of multiple sclerosis International Journal of Clinical Practice 54(3): 161-169
Schuller, E. 1985: Multiple sclerosis. Current etiopathogeny Presse Medicale 14(1): 50
Chofflon, M. 2003: Multiple sclerosis: current therapeutic strategies Revue Medicale de la Suisse Romande 123(1): 27-32
Hanson, L.J.; Cafruny, W.A. 2002: Current concepts in multiple sclerosis: Part I South Dakota Journal of Medicine 55(10): 433-436
Sato, T. 1995: Multiple sclerosis: update on current therapies Rinsho Shinkeigaku 35(12): 1505-1507
Zavalishin, I.A. 1990: Current theories on the etiology of multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(2): 3-8
De Vita, S.; D'Ascanio, A.; Bombardieri, S. 1991: Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases Recenti Progressi in Medicina 82(11): 603-606
Matsushita, T. 2011: Multiple sclerosis: current therapies and future perspectives Nihon Rinsho. Japanese Journal of Clinical Medicine 69(11): 2077-2086
Remes, A.; Airas, L.; Atula, S.; Färkkilä, M.; Hartikainen, Päivi.; Koivisto, K.; Mäenpää, E.; Ruutiainen, J.; Sumelahti, M-Liisa. 2015: Update on Current Care Guideline: Multiple sclerosis Duodecim; Laaketieteellinen Aikakauskirja 131(5): 500-501
Rubio, J.P.; Speed, T.P.; Bahlo, M.; Kilpatrick, T.J.; Foote, S.J. 2000: The current state of multiple sclerosis genetic research Annals of the Academy of Medicine Singapore 29(3): 322-330